NCT00799136
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dendritic Cell Sarcoma, Interdigitating, +25 more
- Locations
-
- Odette Cancer Centre Toronto, Ontario, Canada
- St. Michael's Hospital Toronto, Ontario, Canada
Clinical trial condition
Lymphoma, AIDS-Related
Explore clinical trials studying Lymphoma, AIDS-Related. Study availability and eligibility vary by location and protocol.
17 public trials
2 recruiting studies
Lymphoma, AIDS-Related trial results
NCT00003114
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Completed
A Study of Patients With AIDS Syndrome
NCT00001120
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chromosome Aberrations, +35 more
- Locations
-
- Willow Clinic Menlo Park, California, United States
- San Francisco Gen Hosp San Francisco, California, United States
- Marin County Specialty Clinic San Rafael, California, United States
- San Mateo AIDS Program / Stanford Univ Stanford, California, United States
NCT00001571
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +21 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00002221
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +21 more
- Locations
-
- City of Hope Natl Med Ctr Duarte, California, United States
Active, Not Recruiting
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
NCT03220022
- Conditions
- AIDS-related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, +12 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Memorial Hospital West Pembroke Pines, Florida, United States
Active, Not Recruiting
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
NCT02911142
- Conditions
- B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States